BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing ...

Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon from BC Partners.

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off ...

Goldman Sachs’ asset arm is in the process of acquiring the Dutch pharmaceutical company Synthon International for 2 billion ...

VANCOUVER, BC / ACCESSWIRE / December 16, 2024 / Skeena Resources Limited (TSX:SKE) (NYSE:SKE) ("Skeena Gold and Silver", "Skeena" or the ...

Skeena Resources (TSX: SKE) (NYSE: SKE) has unlocked $195 million in funding for its 100%-owned Eskay Creek project in ...

"Success in China makes you stronger worldwide. That is why we firmly believe that the next 'China is China'. And that ...

Not included on the list was the May 1 fatal shooting of a 14-year-old boy by police outside Mount Horeb Middle School.

The US government says the flying objects pose no threat to national security, but their origin and intentions remain unclear.